Mary Trujillo
Nurse Practitioner · Albuquerque, NMNPI 1669407698
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,563 of the $4,645 with a category attached, or 76.7%. 26 manufacturers reported payments, led by Alphatec Spine, Inc at 42.0% of the total. Reporting peaked in 2021 at $1,679 and has fallen 60.8% since, to $658 in 2025. Among nurse practitioner clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $37.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$2K
- AbbVie$527
- Novartis$295
- Genentech USA, Inc.$258
- CSL Behring$233
- Acadia Pharmaceuticals Inc$184
- plus $1K from 20 others
What the payments were for
- Travel & lodging$1,05723%
- Food & beverage$3,56377%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 22 | $1,951 |
| AbbVie(2 entities) | 15 | $527 |
| Novartis | 13 | $295 |
| Genentech USA, Inc. | 8 | $258 |
| CSL Behring | 9 | $233 |
| Acadia Pharmaceuticals Inc | 9 | $184 |
| Neurocrine Biosciences, Inc. | 3 | $152 |
| Acorda Therapeutics, Inc | 5 | $150 |
| Revance Therapeutics, Inc. | 2 | $140 |
| Eisai Inc. | 5 | $105 |
| Neurelis, Inc. | 4 | $87 |
| Biogen | 4 | $76 |
| Lilly USA, LLC | 4 | $71 |
| SK Life Science, Inc. | 2 | $63 |
| Amgen | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $40 |
| Sanofi | 1 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| AstraZeneca | 1 | $27 |
| UCB, Inc. | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Argenx US, Inc. | 1 | $19 |
| Banner Life Sciences, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Digestive Care, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,645 in reported general payments places this provider in the 95th percentile of 624 nurse practitioner providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $107 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Albuquerque
- Marisa EscobarAlbuquerque$36K
- Catherine SollerAlbuquerque$33K
- Christina ParksAlbuquerque$7K
- Paula JohnsonAlbuquerque$6K
- Nadia Cano VazquezAlbuquerque$6K
- Laura LeblancAlbuquerque$6K
- Dina KotovaAlbuquerque$6K
- Alisha LowdenAlbuquerque$5K
- Lizette Sidransky-UlloaAlbuquerque$5K
- Natasha AbruzzoAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.